Market Cap | ₹200Cr |
ROE | 11.38% |
P/E Ratio(TTM) | 7.62 |
EPS(TTM) | 12.47 |
P/B Ratio | 1.17 |
Dividend Yield | 0.00% |
Industry P/E | 34.70 |
Book Value | 81.48 |
Debt to Equity | 0.00 |
Face Value | 10 |
Parent Organisation | Alpa Laboratories |
Managing Director | Mr. Paresh Chawla |
NSE Symbol | ALPA |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 116.61 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.53 | ||
Emcure Pharmaceuticals | NA (0.00%) | 35.27 | ||
Wockhardt | NA (0.00%) | -197.72 |